Chemistry project that helps local fire department presented at national conference – New Bern Sun Journal

By Deborah Kania, Craven Community College

Fifth-year Craven Early College (CEC) students Emily Chance and Sar Oo attended the 253rdnational meeting of the American Chemical Society held in April in San Francisco, Ca.

Chance and Ooand Craven Community College instructor Don Carpenetti presented, Evaluation and refinement of theprocedure used to prepare training samples for arson detection K-9s.

This chemistry honors program project started in 2015 by former Craven CC students SydneyGiammona and Nicole Miller.

The project has been a collaborative effort between the students, NewBern Fire Department Marshal Danny Miller, and Darby who is a female K-9 arson dog trained as anaccelerant detection canine.

According to Hill, the collaboration between the fire department and chemistry program hasachieved the fire departments goals of acquiring training fuel that is consistent, readily available andaffordable.

We appreciate the help for the training fuel, said Hill.

In fall 2016, Chance picked up where the previous students left off as part of her honors project inchemistry class.

Oo assisted Chance with the laboratory experiments and making of the training fuel.

The students spent extra time out of class to complete the project.

Chance and Oo said they enjoyed learning more about chemistry and its many educational andcareer opportunities at the conference.

They also had some time to tour San Francisco, includingdragging their chemistry instructor around a nine-story mall according to Oo.

Carpenetti also presented, Reciprocal peer tutoring in general chemistry: Benefits to informationretention and lowered student test anxiety, to his peers at the chemistry conference.

Chance and Oo are both graduating from CEC in May with honors and as members of the PhiTheta Kappa international honor society.

Chance will graduate with her high school diploma, and an associate degree in arts, generaleducation and science.

She will attend N.C. State in the fall to study chemistry and forensics.

Afterreceiving my bachelors degree, I would like to enlist in the military, said Chance.

Oo will graduate with her high school diploma, and an associate degree in arts and science.

Shewill attend Elizabeth City State in the fall to study pharmaceutical science.

After college, Oo said shewould like to be a researcher.

The week before the chemistry conference, Carpenetti was honored in Los Angeles as a 2017National Science Teachers Association (NTSA) award winner in the college level category.

Thechemistry project was one of the abstracts he submitted in his application for the annual award. Theseteachers and science education professionals have shown tremendous dedication and commitment totheir students and to science education, noted NSTA President Mary Gromko.

Carpenetti plans to continue to recruit future students to continue working on this project.

Carpenetti said there is more to learn. When you conduct one experiment, it usually creates three orfour more, he said.

Deborah Kania is the director of marketing, communications and development liaison at CravenCommunity College.

Read more:
Chemistry project that helps local fire department presented at national conference - New Bern Sun Journal

Global chemical production ends Q1 with slight decline, ACC says – ChemEngOnline

The American Chemistry Councils (ACC; Washington, D.C.; http://www.americanchemistry.com) Global Chemical Production Regional Index (Global CPRI) shows that the first quarter ended on a soft note, with headline global production slipping back 0.1 percent in March, as measured on a three-month moving average (3MMA) basis. This follows a revised 0.1 percent drop in February and a revised 0.4 percent gain in January. During March, chemical production decreased in every region except Africa & the Middle East and Asia-Pacific. The Global CPRI was up 1.3 percent year-over-year (Y/Y) on a 3MMA basis and stood at 108.9 percent of its average 2012 levels in March.

During March, capacity utilization in the global business of chemistry slipped 0.2 percentage points to 78.0 percent. This is off from 79.4 percent last March and is below the long-term (1987-2016) average of 88.7 percent.

Results were mixed on a product basis during March, with gains in agricultural chemicals, bulk petrochemicals & organics, and plastic resins. Considering Y/Y comparisons, growth was strongest in plastic resins followed by coatings and inorganic chemicals.

ACCs Global CPRI measures the production volume of the business of chemistry for 33 key nations, sub-regions, and regions, all aggregated to the world total. The index is comparable to the Federal Reserve Board (FRB) production indices and features a similar base year where 2012=100. This index is developed from government industrial production indices for chemicals from over 65 nations accounting for about 98 percent of the total global business of chemistry. This data are the only timely source of market trends for the global chemical industry and are comparable to the US CPRI data, a timely source of U.S. regional chemical production.

Original post:
Global chemical production ends Q1 with slight decline, ACC says - ChemEngOnline

Biotechnology | USDA

Advances in science, many of them from scientists at USDA or through research funded by USDA, have opened up new options for farmers responding to market needs and environmental challenges. Many new plant varieties being developed or grown by farmers have been produced using genetic engineering, which involves manipulating the plant's genes through techniques of modern molecular biology often referred to as recombinant DNA technology. These techniques are included in what is often referred to as "biotechnology" or "modern biotechnology."

USDA supports the safe and appropriate use of science and technology, including biotechnology, to help meet agricultural challenges and consumer needs of the 21st century. USDA plays a key role in assuring that biotechnology plants and products derived from these plants are safe to be grown and used in the United States. Once these plants and products enter commerce, USDA supports bringing these and other products to the worldwide marketplace.

Three federal agencies are involved in ensuring that plants produced using biotechnology and the many products derived from them are safe for farmers to use, safe to consume as food or feed, and safe for the environment. These are USDA's Animal and Plant Health Inspection Service, the Department of Health and Human Services' Food and Drug Administration, and the United States Environmental Protection Agency. The three agencies regulate these products based on the characteristics of the actual products and their intended uses, and they operate under the existing laws passed by Congress to ensure the safety of plants used in agriculture, the safety of pesticides used in agriculture, and the safety of foods we eat and feeds given to animals. Many other USDA agencies have roles in the development, use, and marketing of these products as well.

Learn more about How the U.S. Government Regulates Biotech Plants.

Since the first successful commercialization of a biotechnology-derived crop in the 1990s, many new crop varieties have been developed and made available to U.S. farmers and farmers worldwide. U.S. farmers have rapidly adopted many of these new GE varieties, so that in 2012, 88 percent of the corn, 94 percent of the cotton, and 93 percent of the soybeans planted in the U.S. were varieties produced through genetic engineering. A large proportion of the production of other crops, such as alfalfa, and papaya, and sugar beet, is also biotech-derived.

Read more about the reasons behind this trend and about how farming practices and the marketplace have changed on USDA's Economic Research Service Biotechnology page.

The United States is the largest exporter of agricultural products, which helps feed the world's population, and our export markets are critical to the health of U.S. farm communities around the country. Most of the corn and soybeans we export are biotechnology-derived, and this means that working with our trading partners is critical to help them understand the technical aspects of new products and how we have determined that they meet our high safety standards, to open up new markets, and to ensure that our products are treated fairly in the global marketplace.

The increasing use of biotechnology in agriculture has changed, and will continue to change, farming and the work of USDA in the long-term. To help understand and address these changes, USDA established the Advisory Committee on Biotechnology and 21st Century Agriculture (AC21). One critical area where the committee has focused its attention is how farmers who produce different crops intended for different customers-biotechnology-derived, conventional, or organic-can best co-exist and produce the crops that meet their customers' needs. The AC21 has provided a report to USDA, with recommendations, on this subject.

Visit the AC21 page to learn more.

Continue reading here:
Biotechnology | USDA

SQI Diagnostics to Exhibit at the National Biotechnology Conference – Yahoo Finance

TORONTO, May 1, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, will be exhibiting at the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference in San Diego, California.

"We are pleased to be a contributor to this very prestigious conference," said Andrew Morris, CEO of SQI Diagnostics. "This event brings together the world's leading experts and representatives from all sectors of pharma and biotechnology drug development and gives us the opportunity to share our novel multiplexing applications in drug development testing. Over the past year, we have made significant progress in our work with our pharma and biotech customers and believeour unique productswill prove to be beneficial to our customers who are large, global pharmaceutical companies.

The conference will run from May 1-3, 2017. Please stop by and visit us at booth 316.

About SQI Diagnostics

SQI Diagnostics is a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Company's proprietary microarray tests and fully-automated systems are designed to simplify protein and antibody testing workflow, increase throughput, reduce costs and provide excellent data quality. For more information, please visit http://www.sqidiagnostics.com.

Contacts:

Sales and Marketing Contact: Russ Peloquin Vice President, Global Commercial Operations 913.484.9022 rpeloquin@sqidiagnostics.com

Investor Relations Contact: Andrew Morris Chief Executive Officer 416.674.9500 ext. 229 amorris@sqidiagnostics.com

Forward-looking Information

This news release contains certain forward-looking statements, including, without limitation, statements containing the words "will", "may", "expects", "intends", "anticipates" and other similar expressions which constitute "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. The forward-looking statements in this news release include without limitation, statements with respect to the Private Placement and the use of proceeds of the Private Placement. These forward-looking statements involve risks and uncertainties including, but not limited to risks related to the failure to obtain necessary regulatory and stock exchange approvals, general economic and market segment conditions, and international risk and currency exchange risks, agreements and future agreements to sell our products, the success of our Diagnostic Tools and Services business and our intent to build near-term revenue streams from this business, the successful regulatory filing and receipt of regulatory approvals for our later stage quantitative diagnostic kits, the acceleration of our revenue ramp, general economic and market segment conditions, competitor activity, technology changes and regulatory approvals. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company's ongoing filings with the securities regulatory authorities, which filings can be found at http://www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable laws.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the U.S. Securities Act or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Read More

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Originally posted here:
SQI Diagnostics to Exhibit at the National Biotechnology Conference - Yahoo Finance

Animal Biotechnology Technologies, Markets and Companies 2016-2026 – GlobeNewswire (press release)

May 01, 2017 07:30 ET | Source: Research and Markets

Dublin, May 01, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering.

This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture

Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine

Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.

Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.

Approximately 124 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.

Share of biotechnology-based products and services in 2016 is analyzed and the market is projected to 2026.

Key Topics Covered:

Executive Summary

1. Introduction to Animal Biotechnology

2. Application of Biotechnology in Animals

3. A Biotechnology Perspective of Animals Diseases

4. Molecular Diagnostics in Animals

5. Biotechnology-based Veterinary Medicine

6. Research in Animal Biotechnology

7. Animal Biotechnology Markets

8. Regulatory issues

9. Companies Involved in Animal Biotechnology

10. References

For more information about this report visit http://www.researchandmarkets.com/research/6hlgn5/animal

Source: Jain PharmaBiotech

About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Related Articles

Research and Markets Logo

LOGO URL | Copy the link below

Formats available:

See the rest here:
Animal Biotechnology Technologies, Markets and Companies 2016-2026 - GlobeNewswire (press release)

Are you ‘anti-science’ if you resist biotechnology on political or economic grounds? – Genetic Literacy Project

[Editors note: Tess Doezema is a doctoral student at the School for the Future of Innovation in Society at Arizona State University, where she researches biotechnology promise and politics.]

[S]cientists and others offer a picture of a Manichean world divided into those who are for scientific and technological progress and those who are against ita representation of the world that we have been seeing more and more of lately in reports of a war on science. But drawing this line is dangerous. The real problem here is the regulatory process itself, which forces dissent to take the narrow form of challenges to scientific data and methodology and ignores other questions about whats at stake.

Some might read the vast public preoccupation with a broad set of social, political, and economic issues as the contamination of science with politics. But I would suggest that this is actually a case of the reverse problem: seemingly endless conflict around the AquAdvantage salmon reflects the limitation of using narrow scientific terms to address questions of broad social, political, and economic significance.

Scientists often dismiss resistance to the AquAdvantage salmon and other biotechnologies as borne of scientific ignorance. But its a lot easier to understand peoples reluctance if you realize that the debate is about much broader questions than science alone can answer.

Read the original post:
Are you 'anti-science' if you resist biotechnology on political or economic grounds? - Genetic Literacy Project

Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) Soars On Xenetic Biosciences Inc. (NASDAQ:XBIO) Distribution … – StockNewsUnion


The Newburgh Press
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) Soars On Xenetic Biosciences Inc. (NASDAQ:XBIO) Distribution ...
StockNewsUnion
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) continues to power high in the market on the back of a recently announced product distribution deal. A deal with Xenetic Biosciences is expected to make the company's products available on the ...
Traders are Following Technical Levels for Prana Biotechnology Ltd (PRAN)Rives Journal
Does Prana Biotechnology Limited (PRAN)'s current closing price competes the market?TopChronicle
Notable Institutional Stake In These Stocks: Prana Biotechnology (NASDAQ:PRAN), Adamis Pharmaceuticals ...Wallstreet Investorplace
WsNews 4investors -TRA -The Newburgh Press
all 13 news articles »

Read more:
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) Soars On Xenetic Biosciences Inc. (NASDAQ:XBIO) Distribution ... - StockNewsUnion

379,289 Shares in Puma Biotechnology Inc (PBYI) Acquired by … – The Cerbat Gem


USA Commerce Daily

See the original post:
379,289 Shares in Puma Biotechnology Inc (PBYI) Acquired by ... - The Cerbat Gem

Interview: Adam Piore And The Jaw-Dropping Science Of Bioengineering – WSHU

In his new book, The Body Builders: Inside the Science of the Engineered Human,author and award-winning journalist Adam Piore says the new frontier that intrigues scientists and engineers today is the human body.

He says amazing work and research is underway that melds technology with biology.These innovations can heal devastating injuries or even rewire the brain.

Piore tells us about this evolving science through the stories of the people who develop the technology and the people who are transformed by it.

Piore recently sat down with All Things Considered Host Bill Buchner. Below is a transcript of their conversation.

You are a journalist by profession, a foreign correspondent at one point.So how did you come to write this book?

I covered a lot of things, I covered Congress, I lived in Cambodia, and I went to Iraq, but one of the things that has always intrigued me in my journalism is stories of human resilience.Its always fascinated me how people overcome adversity and are able to live with setbacks.

So a few years ago I came across the story of an incredible scientist named Hugh Herr.And his story so fascinated me that I sort of followed along that path and went sort of down the rabbit hole into these new technologies bioengineering which are unleashing untapped resilience in the human body.I found that the most exciting stories of human resilience in the United States are often being unleashed by these biotechnologies.

Speaking of Hugh Herr, he survived a rock climbing incident that led him to develop more advanced forms of prosthetic legs that he calls wearable robots. Would you tell us about that?

Hugh had a really remarkable story.He was not that great a student when he was a teenager, he was a C and D student, but he lived to rock climb and he was a nationally known athlete, one of the best up and coming rock climbers in the country.He went ice climbing with a friend in New Hampshires Mount Washington.They got stuck in a blizzard and they wandered into the wilderness, and they got lost and they almost died.They were saved at the last moment but not in time to save them completely.They both had frostbite and Hughs legs were amputated below the knees.

And the doctors told him he would never run or climb again.And every day, he would wake up dreaming that he was running through the cornfields behind his house, and then hed wake up and his legs would be gone.But he didnt stay in bed very long. He began tinkering with his prosthetics and he was back on the climbing wall. And he made them seven-feet long and he made blades that he could slip into crevices.And he became an even better rock climber than he had been before.

And this tinkering sort of led him to tinker when he was down on the ground because his prosthetics were so uncomfortable.He began taking engineering classes.And flash forward 20 or 30 years, hes one of the leading bioengineers and prosthetic engineers in the world.Hes at MIT.And he has designed these bionic limbs that really kind of show whats possible, that allow him to walk again.

Pat Fletcher is featured in the part of your book where you explore how bionics can enhance our senses.Fletcher survived an industrial accident which left her blind. Twenty-five years later, she was able to use new technology that allowed her to see with her ears.How likely are we to see more Pat Fletchers out there with this type of technology?

Where Hugh just wanted to climb and run, Pat loved nature and she was blinded in a grenade factory explosion and could no longer see and years later she is seeing mountains again.Its an example of the incredible plasticity of the human mind.What she discovered online was this device that was created by this Dutch engineer, which they call a sensory substitution device and its based on this insight that we see with the brain and not the eyes.

If we can get the information from the outside world into our brain, its the worlds most sophisticated pattern recognition machine. What this device does is it takes the pixel in pictures and turns them into different tones, sort of like a wall of sound.Over time Pats brain learned to recognize these sounds and route them to her visual cortex. And she can actually make sense of the world. Shes regained depth perception. She can see the leaves on trees, she can see mountains.She can see the cracks on sidewalks.Its pretty remarkable.

Continued here:
Interview: Adam Piore And The Jaw-Dropping Science Of Bioengineering - WSHU

Bioengineering graduate takes off at Rocket Lab | Scoop News – Scoop.co.nz (press release)

Bioengineering graduate takes off at Rocket Lab

When Alex Anderson was a teenager growing up in Waiuku, he read a lot of science fiction and dreamt of one day building futuristic things like robots.

Today Alex has arguably done even better than that. The 30-year-old Mt Eden resident who graduates from the University of Aucklands Bioengineering Institute with a PhD in Biomedical Engineering, is now building rockets for a living.

Its a dream job, he says of his role with Rocket Lab.

Rocket Lab is a US company with a base of operations in New Zealand.

They are developing launch vehicles to put small satellites into space, explains Alex. These satellites traditionally have to compromise on orbit to ride share with larger satellites.

Rocket Labs Electron will lower the barrier to commercial space by offering frequent and cheap launches direct to orbit from the Mahia Peninsula on the North Islands East Coast.

Alex is a vehicle test engineer with Rocket Lab and says his role involves testing all the various components and systems which make up a launch vehicle and feeding the results of those tests back to the designers.

He has drawn on his general engineering background in instrumentation and electronics, as well as the training hes received in scientific method (for example striving for rigorous tests) to do his job.

Alex is a good example of how transferrable Bioengineering skills can be to a broad range of industries and applications, says his PhD supervisor Associate Professor Andrew Taberner.

For his PhD, Alex developed a new scientific instrument for studying tissue extracted from a living heart. In this device, a pulse of electricity causes calcium ions to be released into living muscle cells. This stimulates the cells to shorten, change shape, release heat and perform work.

Alex's instrument is the first to allow all of these events to be observed together, says Associate Professor Taberner. It will enable a deeper study of the relationships between the systems driving the heart, in health and disease.

https://www.rocketlabusa.com

http://www.abi.auckland.ac.nz/

http://www.abi.auckland.ac.nz/

Scoop Media

Read more here:
Bioengineering graduate takes off at Rocket Lab | Scoop News - Scoop.co.nz (press release)

Newest NSF Honorees Share Devotion to Improving Our World – University of Texas at Dallas (press release)

Text size: research 11 UT Dallas Students, Alumni Receive National Science Foundation Graduate Research Fellowships

May 2, 2017

The best and brightest students at The University of Texas at Dallas seek out opportunities to use their expertise and passion to work for the betterment of humanity. Jenny Boothby is one such researcher, envisioning advances to point-of-care technology that would allow diagnosis of diseases to occur as quickly as litmus paper changes color.

Boothby, a doctoral student in the Department of Bioengineering, is among 11 students with ties to UT Dallas chosen this year for the Graduate Research Fellowship Program by the National Science Foundation (NSF). The program provides three years of financial support for graduate studies, each year consisting of a stipend of $34,000 plus a $12,000 cost-of-education allowance.

Boothby arrived from Georgia Tech in the fall of 2015 to work in the lab of Dr. Taylor WareMS'11, PhD'13, assistant professor of bioengineering, on formulating smart materials for biomedical applications. Her work has focused on liquid crystalline films commonly used for products such as LCD screens, but not yet utilized in a biological setting.

NSF Graduate Research Fellowship Program

The National Science Foundation Graduate Research Fellowship Program is the countrys oldest fellowship program that directly supports graduate students in various STEM (Science, Technology, Engineering and Mathematics) fields. This year, 2,000 awards were offered from nearly 13,000 applicants. The award includes a three-year, $34,000 annual stipend plus a $12,000 educational allowance that goes toward tuition and fees.

We think these polymers can be applicable to biomedical engineering because we can control their order, their molecular structure, so well, Boothby said. My specific research is tuning these polymers to be water-responsive so that they can be used in a device in the body, like a heart valve, but without needing an external power source.

Boothbys eventual goal involves point-of-care biosensors for developing countries, such as powerless devices capable of replacing expensive, unwieldy electrical equipment for running medical lab tests.

These small devices would enable you to apply a sample to the device and figure out what disease someone has based on the color change, Boothby said. No lab, no reagents you can fit everything into this piece of plastic. It would open up access to so many more people.

Boothbys determination to expand the availability of such technologies crystallized with the help of several experiences beyond our borders, including service trips to Peru and the Dominican Republic.

Through both of those, I developed this belief thatits our duty to help others. I feel fortunate to have an opportunity to work on this technology that could bridge that gap, to create something thats applicable in all environments everywhere, instead of only in resource-rich environments.

Interim vice president for research Rafael Martn believes the sharp increase in UT Dallas honorees indicates both the Universitys growing profile nationwide as well as the strength of UT Dallas programs across many disciplines.

These awards are a tremendous external validation of the quality of both our undergraduate and graduate students, Martin said. UT Dallas has been recognized for some time for our academically exemplary undergraduate population. That NSF Graduate Research Fellows are choosing to pursue their graduate education here demonstrates a growing awareness of the quality of our graduate programs and students as well.

Two UT Dallas alumni who chose to continue their doctoral studies at the University also received NSF fellowships.

Like Boothby, fellowship winner Candace Benjamin came to UT Dallas from out of state. A 2014 graduate of St. John Fisher College in New York, Benjamin is a chemistry doctoral student in the lab of Dr. Jeremiah Gassensmith. Her work concerns developing a virus-like particle as a possible carrier for medication.

Two UT Dallas graduates whose graduate studies have taken them to other prestigious universities were also selected by the NSF.

The NSF also chose five students who are expected to earn their undergraduate degrees from UT Dallas in May.

Media Contact: Stephen Fontenot, UT Dallas, (972) 883-4405, [emailprotected] or the Office of Media Relations, UT Dallas, (972) 883-2155, [emailprotected]

Read the original here:
Newest NSF Honorees Share Devotion to Improving Our World - University of Texas at Dallas (press release)

Students Inducted into Honor Society, Win Awards At American … – Wesleyan Connection (blog)


Wesleyan Connection (blog)
Students Inducted into Honor Society, Win Awards At American ...
Wesleyan Connection (blog)
Julianne Riggs '17 in Chicago last month, where she attended the American Society for Biochemistry and Molecular Biology meeting. Five Wesleyan seniors ...
Prebiotic Qualities of Dried Plums Identified as a Colon Cancer ...Oncology Nurse Advisor

all 2 news articles »

See the rest here:
Students Inducted into Honor Society, Win Awards At American ... - Wesleyan Connection (blog)

UNCW receives largest ever donation, gift will support pharmaceutical and chemistry programs – Port City Daily

PortCityDaily.com is your source for free news and information in the Wilmington area.

WILMINGTON The University of North Carolina Wilmington received a multi-million dollar gift today.

Quality Chemical Laboratories pledged a $5 million gift, to be donated over the next five years. The donation is the largest corporate philanthropic gift in the Universitys history. Quality Chemical Laboratories founder, Dr. Yousry Sayed is a longtime UNCW faculty member in the chemistry department. His wife, Linda Sayed, is a graduate of the University.

UNCW Chancellor Jose Sartarelli said the announcement was some time in the making.

We have been working on this for about a year, Sartarelli said. I have become involved more recently. Aswani Volety, our Dean of the College of Arts and Sciences, was very involved. This was a confluence of good things and good timing.

The Sayeds donation to UNCW will support new programs aimed at advancing study in pharmaceutical and chemistry. According to the administration hopes the gift will help the University further develop recent advances in chemistry, biochemistry, biology and marine biology. Over the coming years, the gift will provide funding for establishing distinguished professorships and research, and may also help support scholarships, faculty research and travel grants.

Sartarelli said the programs will help the school meet the current needs of the state and the growing health care market.

The programs will be under the department of chemistry and biochemistry. Were starting with a Masters program, and we hope to develop a Ph.D. program as well. The goal, of course, is to help connect our students with the growing field of health sciences, with clinical research organizations and testing.

Quality Chemical Laboratories employs many UNCW graduates from the chemisty and biochemistry programs, according to Sartarelli. He hopes the Sayeds gift will help prepare future graduates for similar jobs across the state.

In a press release, Dr. Sayed said he and his wife were happy to be able to give back to their University.

It is an honor to be able to make this small contribution to this great university we love and appreciate, and to invest in the future of this important area of study and the students we serve, said Sayed. My wife and I have been a part of the Seahawk family and have grown together with UNCW for decades, and to know we are contributing to the universitys mission and outcomes in some small way is very rewarding for us.

See the rest here:
UNCW receives largest ever donation, gift will support pharmaceutical and chemistry programs - Port City Daily

Anatomy of a Stokes masterclass – ESPNcricinfo.com

Rising Pune Supergiant v Gujarat Lions, IPL 2017, Pune May 1, 2017

Rising Pune Supergiant were 10 for 3 in their chase of 162, and then 42 for 4, but nothing, not even a prolonged bout of cramps, was going to stop Ben Stokes

Star turn

Ever since the last World T20 final, when he was hit for four sixes in the final over of the chase, Ben Stokes has been the subject of some ridicule, especially when sold for a record sum in the IPL auction. Two days before he goes back to his house of horrors, Eden Gardens, Ben Stokes produced one of the great Twenty20 innings. And he did so while hobbling with a cramp in his calf in the last three overs of the chase. Nothing can wipe off what happened in Kolkata last year, but Stokes has done enough in this IPL season to quell those doubts around him.

Coming into this match, Stokes had won two match awards but both for bowling. He had scored only 127 from seven innings before this, but in Pune, coming in to bat in the second over, at the fall of the third wicket. he scored 63% of his team's total. He had batted sooner in an innings only four times before that.

In his 126 a night before, a near-perfect T20 innings, David Warner batted with a 78% control percentage, which is phenomenal when you are attempting to hit a boundary every second ball. Stokes displayed 79% control. That control percentage was bound to be higher because he hit only one boundary every five balls as against Warner's one every three balls, but the fact Stokes couldn't afford to keep swinging made this innings special.

Stokes also struggled against legspinner Ankit Soni. He picked the wrong 'uns out of the back of the hand, but the sliders out of the front of the hand kept going past his outside edge. The 11 balls Soni bowled to Stokes, for seven runs, brought his control percentage down. So Stokes had to strike against others but in a calculated manner because four wickets fell within the first six overs, and because MS Dhoni faced 10 dots in his first 12 balls.

So Stokes struck against Ravindra Jadeja to break the shackles, and then kept finding the boundary every time the asking rate threatened to go out of hand.

The wow moment

Things can happen before you realise in T20 cricket. You are four down early, you are looking to arrest the slide, and two spinners can run through six overs in no time. When you look up at the board, you can be staring at an unachievable asking rate. The previous 19 balls had got Rising Pune just nine runs, with the asking rate shooting from 8.5 to 10. Then Stokes swung. Bang and bang, Ravindra Jadeja was hit over midwicket and long-on. The innings was back on track, and this was the last over Jadeja bowled because Gujarat Lions couldn't get rid of Stokes at all.

ESPNcricinfo Ltd

Stats that matter

What they said

"Stokesy is a quality player and he certainly earned his cash." Enough said, captain Steven Smith

"We lost quite a few early wickets... Me and MS [Dhoni] just tried to keep it ticking. We just tried to go big at the start of the over, and cool it off." Ben Stokes on how he approached the chase

Sidharth Monga is an assistant editor at ESPNcricinfo

ESPN Sports Media Ltd.

Read the original here:
Anatomy of a Stokes masterclass - ESPNcricinfo.com

‘Grey’s Anatomy’ Star Jesse Williams Reportedly Left His Wife and Kids For Minka Kelly – Maxim


Maxim
'Grey's Anatomy' Star Jesse Williams Reportedly Left His Wife and Kids For Minka Kelly
Maxim
'Grey's Anatomy' Star Jesse Williams Reportedly Left His Wife and Kids For Minka Kelly. Damn, dude. Avatar: Author: Brandon Friederich; Publish date: a few seconds ago; Social count: 0. Damn, dude. 0. SHARES. 0; 0; 0; 0. GettyImages-112100008.
Greys Anatomy star Jesse Williams is still focused on his family despite the split from his estranged wifeRare.us
Jesse Williams divorce: He's moved out but has been visiting his kidsWonderwall
Jesse Williams Moving Out and Moving On But Still There for the KidsTMZ.com
Blasting News
all 17 news articles »

Link:
'Grey's Anatomy' Star Jesse Williams Reportedly Left His Wife and Kids For Minka Kelly - Maxim

‘Grey’s Anatomy’ Season 13 Finale Synopsis Revealed – Wetpaint – Wetpaint

Credit: Richard Cartwright/ABC 2017 Disney | ABC Television Group. All rights reserved.

With only three installments left in Greys Anatomy Season 13, were already getting jittery thinking of all the drama the season finale will unleash.

And a new synopsis from ABC only ups the anxiety!

Per Screener, heres ABCs first synopsis for the May 18 season-capper:

A dangerous patient escapes the hospital room, putting the doctors lives at risk; Alex faces a difficult decision in his relationship with Jo; Meredith has big news for Nathan.

Lets break down that tease clause by clause. First up: A dangerous patient escapes the hospital room, putting the doctors lives at risk.

If a fire does indeed break out at Grey Sloan Memorial, we imagine its this patient who starts it. Perhaps dangerous is code for pyromaniac here.

(The synopsis for the preceding episode also mentions a dangerous patient, whom we imagine is the same person.)

Next, Alex faces a difficult decision in his relationship with Jo.

One week earlier, hell attend a medical conference after making a shocking discovery, that episodes synopsis reveals.

Were guessing that shocking discovery will be the identity of Jos abusive husband, maybe the character Glee star Matthew Morrison is playing, as fans are conjecturing. (Matthews character is another guest at that conference, after all.)

So perhaps Alex will be dealing with the fallout of his encounter with Jos ex when the finale rolls around.

Then again, Shonda Rhimes always subverts our expectations, and wed bet good money she wants us to think big news will mean big baby bump just so well be caught off-guard by a season finale curveball.

But how does she expect us to sleep between now and May 18?!

Greys Anatomy Season 13 airs on Thursdays at 8 p.m ET on ABC.

The rest is here:
'Grey's Anatomy' Season 13 Finale Synopsis Revealed - Wetpaint - Wetpaint

Scoop: GREY’S ANATOMY on ABC – Thursday, May 18, 2017 – Broadway World

On the episode Ring of Fire, the doctors lives are at risk after a dangerous patient escapes the hospital room. Alex must make a hard choice in his relationship with Jo while Meredith has some big news for Nathan that brings things to a turning point, on the season finale of Greys Anatomy, THURSDAY, MAY 18 (8:00-9:01 p.m. EDT), on The ABC Television Network.

Greys Anatomy stars Ellen Pompeo as Meredith Grey, Justin Chambers as Alex Karev, Chandra Wilson as Miranda Bailey, James Pickens Jr. as Richard Webber, Kevin McKidd as Owen Hunt, Jessica Capshaw as Arizona Robbins, Jesse Williams as Jackson Avery, Sarah Drew as April Kepner, Caterina Scorsone as Amelia Shepherd, Camilla Luddington as Jo Wilson, Jerrika Hinton as Stephanie Edwards, Kelly McCreary as Maggie Pierce, Jason George as Ben Warren, Martin Henderson as Nathan Riggs and Giacomo Gianniotti as Andrew DeLuca.

Greys Anatomy was created and is executive produced by Shonda Rhimes (Scandal, How to Get Away with Murder), Betsy Beers (Scandal, How to Get Away with Murder) and Mark Gordon (Saving Private Ryan). William Harper, Stacy McKee, Zoanne Clack and Debbie Allen are executive producers. Greys Anatomy is produced by ABC Studios.

Guest Starring are Debbie Allen as Catherine Avery and Marika Dominczyk as Eliza Minnick.

Ring of Fire was written by Stacy McKee and directed by Debbie Allen.

Greys Anatomy is broadcasted in 720 Progressive (720P), ABCs selected HTV format, with 5.1-channel surround sound.

View post:
Scoop: GREY'S ANATOMY on ABC - Thursday, May 18, 2017 - Broadway World

Mother Makes Ultimate Sacrifice for Unborn Child on ABC’s Grey’s Anatomy – LifeNews.com

In a society where preborn children are treated as disposable property, and disregarded in the name of cold, sterile, euphemisms such as reproductive rights and choice, its rare to find a mother who actually does the opposite of putting herself above her child.

But in April 27ths episode of Greys Anatomy on ABC, we got to see that rarity played out in a heart-wrenching yet inspiring storyline.

Patient Veronica is in the ER at Grey-Sloan Memorial Hospital for back pain. Shes almost 35 weeks pregnant and her body is riddled with cancer. She decided to forgo cancer treatment because, as she put it, I didnt want to microwave the baby.

The storyline is a continuation from earlier this season when Veronica refused to abort her baby despite pressure from Doctor Miranda Bailey (Chandra Wilson) to kill her child to begin treatments for her terminal pancreatic cancer. (See previous article for factual information on cancer during pregnancy as well, as this episode did not accurately reflect the truth on the effects of chemotherapy and radiation on a preborn baby.)

The prognosis isnt good, as was expected, and as Veronica planned for. The doctors give her two months at best left to live, as the cancer has spread even further and is compressing her spinal cord. And they tell her that they must deliver the baby that day.

Follow LifeNews.com on Instagram for pro-life pictures.

All right. Lets cheer up, everybody. Were having a baby, Veronica announces optimistically, looking forward to having two months to spend with her baby and the babys father.

But during the C-section, things take a turn for the worst:

Amelia: Heart rates up to 130. Veronica, hows yourbreathing?

Veronica: Its fi um, its a little tough.

Jeremy: Whats happening? Whats going on?

Veronica: Hey, Jer, come on. Look at him.He has the sweetest eyes.

Arizona: Her sats are dropping. Shes persistentlytachycardic.

Amelia: Lets put her back on high-flow oxygen.It could be an embolus.

Veronica: Time to get him out of here.

Alex: Yeah, in a minute.

Arizona: If its an embolus, we dont have a minute.

Alex: She did all this so she can meet the baby.Just give them another damn minute.

Veronica: Jer, can you take him?

Alex: He needs to go to the NICU now.

Jeremy: And, uh, what what about Veronica?

Alex: Shes in good hands. Shell be just fine.Ill take good care of her.

Veronica: Jer, you stay with him.You promised. Im counting on you.

Jeremy: But I dont

Veronica: Go on. Stay with him.Ill see you in a little bit.

Amelia: Are we pushing heparin or going straightto thrombolytics?

Arizona: Thrombolytics are contraindicated.We need to do an embolectomy, and lets getan ivc filter.

Amelia: Veronica, youve thrown a blood clot,and its traveled all the way to your lungs.Its very serious. We need to remove it immediately,so were gonna need to put you under andopen up your chest.

Veronica: Is thatUhUh, will that work?

Amelia: The procedure will only last about a halfan hour.

Veronica: Will it work?

Amelia: Theres no guarantee youd survive it.

Veronica: And what if we didnt do anything?

Arizona: Veronica, we need to do this procedure.If we dont, you might not make it off thistable today.

Amelia: Okay, pressures dropping. Get a cart ready!

Veronica: No. I signed that dnr for a reason.

Arizona: You can rescind. Let us help you.

Veronica: I did what I wanted. My babysokay.It Im so tired.

Amelia: I know.I know.

Too bad Dr. Miranda Bailey wasnt around to see that beautiful baby alive and well thanks to his mother not listening to her pro-abortive advice.

Later, we see Veronica in her last moments and realize even further what an amazing mother she was to give up her own life for her childs:

Amelia: What do you want? What do you needright now?

Veronica: Im so cold.

Amelia: Ill get a warming blanket.

Veronica: No! No.Can you Will you just hold me?We did good?The babys good?

Amelia: Babys good.

Yes, Veronica, you did good. And your baby is so very good because of your beautiful sacrifice.

LifeNews Note: Dawn Slusher writes for Newsbusters, where this originally appeared.

Original post:
Mother Makes Ultimate Sacrifice for Unborn Child on ABC's Grey's Anatomy - LifeNews.com

Production halts on ‘The Last Ship’ while its star Eric Dane battles depression – NEWS.com.au

Actor Eric Dane is taking a hiatus from his show to battle depression.

ONE of the best loved stars from Greys Anatomy Eric Dane has taken an indefinite hiatus from his new show The Last Ship to battle depression.

A representative for the actor announced the US navy show would take a brief production hiatus to allow Dane, who is the star of the show, to recover.

Eric asked for a break to deal with personal issues, a representative for the actor told People. He suffers from depression and has asked for a few weeks of downtime and the producers kindly granted that request. He looks forward to returning, he added.

Eric Dane on his TNT show The Last Ship.Source:Alamy

Dane shot to fame for his role as the good looking doctor McSteamy on Greys Anatomy. He starred on the hit medical drama until the shows ninth season in 2012.

The actor has been very open about his struggles in the past.

He announced he was going to rehab in 2011 for an addiction to painkillers from a sports injury and he and his wife Rebecca Gayheart made headlines in 2009 when they became the victims of a leaked, nude video with former Miss Teen USA Kari Ann Peniche.

Dane married Gayheart, who is also an actor, in 2004 and they have since had two girls Billie, seven, and Georgia, five.

Dane with his wife Rebecca Gayheart in 2010. (Picture: Frazer Harrison)Source:AFP

Since his stint in rehab, the actor seemed to be doing well.

I honestly think Im exactly where Im supposed to be at this moment in time, the actor, 44, told PEOPLE in 2014. And Im really happy.

Weve all made mistakes. My one regret is that I got the person I love most wrapped up in all that: Rebecca, Dane added.

The fourth season of The Last Ship is set to premiere in a few months and the show has already been renewed for a fifth season.

The navy drama is a hit for the US cable channel TNT with an average of more than 7 million viewers per episode.

Link:
Production halts on 'The Last Ship' while its star Eric Dane battles depression - NEWS.com.au

Anatomy of the "Adulting" Trend – ELLE.com

Right now, Merriam-Webster Dictionary counts "adulting" among its "words we're watching," or words up for inclusion in the actual dictionary. On Twitter, the #adulting hashtag is used near-incessantlyeven Starbucks replies to tweets with "Adulting WIN!" and a trophy emoji. There's even an "Adulting School" in Portland, Maine., offering crash courses in the basics of life managementfor a monthly "subscription fee" of $19.99. Adulting School students can soon test for their own "Adulting Quotient," or AQ. The AQ, just like an IQ, is a score measuring just how good you are at life-planning, task management, and more. Students are usually youngerbut co-founder Katie Brunelle says they've heard from wannabe "adults" as old as 40.

Advertisement - Continue Reading Below

In March, YouTube personality Arden Rose published Almost Adulting: All You Need to Know to Get it Together (Sort Of). Rose's book features actual checklists for readers to record milestones and important lessons about how things cost money. In the self-help section in any bookstore, you'll find Adulting: How to Be a Grown-Up in 468 Easyish Steps, published in 2013, and new Gracious: A Practical Primer on Charm, Tact and Unsinkable Strength, or titles like Adulting 101 and Why Didn't They Teach Me This in School?

The word is now so ubiquitous, it's hard to tell exactly where its quasi-ironic, quasi-earnest usage began, but the most logical point of origin is with a playful hashtag popularized by Kelly Williams Brown's AdultingBlog.com. In 2013, Brown offered tips on cleaning your house, making a grocery list, saving money, and other hallmarks of the genre. "I think of adulting as best practices for getting your little corner of the world in order," Brown told me in an interview. "Like buying toilet paper in bulkit's not a moral judgment, if you do or if you don't, and sometimes you won't be able to. But when you can do that, it makes all of your life easier, because then you don't run out of toilet paper."

In the years since the word first prominently appeared, it's taken on a new life: part humblebrag and part self-deprecation. When we joke about "adulting""I cleaned out the fridge! #adulting" or "Working on my taxes and ugh, I hate adulting"we're poking holes in the idea that it's a process with an end goal: a dreamy vision of prepared adulthood, always out of reach. You post a photo of a Luna bar captioned"balanced dinner #adultingfail"to roll your eyes at the idea of ever reaching that picture-perfect stage of adulthood promised to us in sponsored content.

Part of the term's popularity, of course, lies with social media: the new world where people can present curated versions of their lives, with #adultingwin posts on full display for others to envy.

But there's something else to its recent rise, tooin acknowledged #adulting fails we're also reminding ourselves that despite our differences in age or background, we all still feel like children sometimes.

Advertisement - Continue Reading Below

And like any catchphrase, much of its prominence can be attributed to market forces; commercial interests saw a buzzword with monetary appeal, and an ad campaign was born. According to Digiday, companies selling everything from coffee to candy have used "adulting" in advertising. Nestl went so far as to set up an "adult help line" for Nescaf Canada, mocking younger generations' reliance on YouTube videos and wikiHow tutorials for basic help. Their "common adulting situations" include: "Dryer Sheets: Friend or Foe?" and "Big Trouble with Small Appliances." "Adulthood is hard, but we think we can help Nestl make it easier on millennials," Nestle's agency partner told Shopify. "We want to let millennials know we get it, that life can be complicated, but that we have a product that's easy and helpful to them in their transition."

Read this article:
Anatomy of the "Adulting" Trend - ELLE.com